All In Biotech

Drug Trial Radar · NCT06728176

Safety and PK of Multiple Doses of MT1988

A Single Centre, Double Blinded, Randomised, Parallel Arm, Placebo Controlled Study to Evaluate the Safety and Pharmacokinetics of MT1988 in Healthy Adults

Last checked: Nov 19, 2026Latest source record: Apr 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

42

Actual

Start

Nov 25, 2024

Primary completion

Apr 8, 2025

Study completion Apr 10, 2025

Sponsor

Lead sponsor
Monument Therapeutics LimitedIndustry
Sponsor type
Industry
First posted
Dec 11, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to assess the tolerability and amount of drug in the blood when four dose levels of MT1988 are administered for 14 days to healthy volunteers. The main question it aims to answer is: * what side effects are seen while administering MT1988 for 14 days? * how much of MT1988 can be measured in the blood at the beginning and end of administering MT1988 for 14 days? Researchers will include a placebo arm (dummy drug) to compare the side effects. Participants will: * take MT1988 every day for 14 days * visit the clinic once per week for assessments * keep a diary to record information between clinic appointments.

Conditions

  • Healthy Volunteer

Interventions

  • MT1988Drug

    Active Drug

  • PlaceboDrug

    Placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment-emergent adverse eventsTime frame: From Day 1 to end of follow up (Day 21-28)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • BDD Pharma Ltd

    Glasgow, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.